Pages that link to "Q64112827"
Jump to navigation
Jump to search
The following pages link to Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (Q64112827):
Displaying 50 items.
- Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota (Q64097144) (← links)
- Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis (Q64113274) (← links)
- Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's: Abundance, Activation and Antigen-Delivery. (Q64880656) (← links)
- Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies. (Q64950921) (← links)
- Neoadjuvant checkpoint blockade for cancer immunotherapy (Q89453914) (← links)
- Prognostic Biomarkers for Melanoma Immunotherapy (Q89669628) (← links)
- Endoplasmic Reticulum-Associated Degradation-Dependent Processing in Cross-Presentation and Its Potential for Dendritic Cell Vaccinations: A Review (Q89762172) (← links)
- DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation (Q89965518) (← links)
- Dilemma and Challenge of Immunotherapy for Pancreatic Cancer (Q90096935) (← links)
- An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses (Q90316720) (← links)
- Tissue-resident memory CD8 T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells (Q90339758) (← links)
- Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity (Q90362022) (← links)
- Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer (Q90404866) (← links)
- Immunomodulatory Drugs Encoded by Oncolytic Viruses: Is the Whole Greater Than the Sum? (Q90503462) (← links)
- The expanding landscape of inflammatory cells affecting cancer therapy (Q90590486) (← links)
- Sufficiency of CD40 activation and immune checkpoint blockade for T cell priming and tumor immunity (Q90660461) (← links)
- Identification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis (Q90661076) (← links)
- The Biology of Immune-Active Cancers and Their Regulatory Mechanisms (Q90677031) (← links)
- The Paradox of Cancer Immune Exclusion: Immune Oncology Next Frontier (Q90677037) (← links)
- In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea? (Q90705224) (← links)
- Immune Cell PD-L1 Colocalizes with Macrophages and Is Associated with Outcome in PD-1 Pathway Blockade Therapy (Q90730277) (← links)
- Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome (Q90862879) (← links)
- Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization (Q90975428) (← links)
- Teamwork by different T-cell types boosts tumour destruction by immunotherapy (Q90975742) (← links)
- Engineering dendritic cell vaccines to improve cancer immunotherapy (Q91496410) (← links)
- Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies (Q91650557) (← links)
- LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects (Q91677839) (← links)
- A conserved dendritic-cell regulatory program limits antitumour immunity (Q91739840) (← links)
- Type I Interferons and Cancer: An Evolving Story Demanding Novel Clinical Applications (Q91810330) (← links)
- Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours (Q91874722) (← links)
- Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors (Q91973531) (← links)
- Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment (Q92072042) (← links)
- Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon? (Q92132117) (← links)
- Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy (Q92267162) (← links)
- High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model (Q92479452) (← links)
- Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion (Q92538625) (← links)
- Tuning the Tumor Myeloid Microenvironment to Fight Cancer (Q92556918) (← links)
- Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set (Q92587245) (← links)
- Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches (Q92626003) (← links)
- Improving nanotherapy delivery and action through image-guided systems pharmacology (Q92644551) (← links)
- Peripheral Circulating CD45RA-FOXP3hi T Regulatory (TReg) II Cells Provide a Window into the Activity of Intratumoral TReg Cells (Q92736057) (← links)
- Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas (Q92946987) (← links)
- HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors (Q93012189) (← links)
- Dendritic Cells and Cancer: From Biology to Therapeutic Intervention (Q93060366) (← links)
- Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy (Q93079047) (← links)
- DNT Cell-based Immunotherapy: Progress and Applications (Q93198646) (← links)
- A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy (Q93216487) (← links)
- NF-κB in the New Era of Cancer Therapy (Q94683589) (← links)
- Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy (Q95643235) (← links)
- The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies (Q95840987) (← links)